SAN DIEGO, Oct. 27 /PRNewswire/ -- Organovo, Inc., a regenerative medicine company focused on bioprinting technology, announced today the appointment of Robert Baltera, M.S., M.B.A, to its board of directors. Baltera is the Chief Executive Officer of Amira Pharmaceuticals in San Diego and has over 19 years of pharmaceutical and biotechnology experience.
In his role leading Amira Pharmaceuticals, Baltera has been instrumental in focusing the company’s development efforts, strengthening and developing its pipeline and forging key collaborations with partners such as GlaxoSmithKline.
About Organovo, Inc.
Organovo, Inc.
